AstraZeneca vaccine is renamed

Changing the name it is not associated with a change in medicationbut stresses that it is important for immunization officials to be aware that product information, labeling and packaging will be different.

In recent days, they confirmed the AstraZeneca vaccine and the University of Oxford to be 76% effective against symptomatic forms of coronavirus, after updating of clinical trial data United States, Peru and Chile.

The results of the “Primary analysis of phase III trials (of the vaccine) in the United States confirmed that (its) efficacy was consistent” with previously announced data, AstraZeneca said in its memo.

The laboratory also indicated that its vaccine was 100% effective in preventing severe cases of Covid-19, a figure similar to that previously announced.